Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RASBURICASE vs RAVULIZUMAB-CWVZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RASBURICASE vs RAVULIZUMAB-CWVZ: Safety Overview

Metric RASBURICASE RAVULIZUMAB-CWVZ
Total FAERS Reports 885 10,229
Deaths Reported 167 551
Death Rate 18.9% 5.4%
Hospitalizations 412 1,663
Average Patient Age 51.8 yrs 55.5 yrs
% Female Patients 36.3% 53.8%
Manufacturer Sanofi-Aventis U.S. LLC N/A
Marketing Status Prescription Prescription